Video: Advances in Breast Cancer Research

Runtime
16:00

Surgical pathologist Jorge Reis-Filho of Memorial Sloan Kettering explains that microarray “gene chips” could be used to identify breast cancer patients who would benefit from chemotherapy, but could not be used to determine which type of chemotherapy would be most effective.

New technology uses a supercomputer to analyze tiny bits of DNA from cancer cells. Multidisciplinary cancer teams, such as the breast cancer team at Memorial Sloan Kettering Cancer Center, can use this information to select the therapy or combination of therapies that will address all of the genetic defects within a single tumor. This technology is also being used to understand why some cancer cells spread, and to develop new therapies for metastatic breast cancer.